Cabotegravir Plus Rilpivirine Long-acting Regimen in the Swiss HIV Cohort Study: Uptake, Outcome, and Risk Factors for Treatment Failures in a Real-world Setting
Latest Information Update: 14 May 2024
At a glance
- Drugs Cabotegravir (Primary) ; Cabotegravir (Primary) ; Rilpivirine (Primary) ; Rilpivirine
- Indications HIV infections
- Focus Therapeutic Use
- 14 May 2024 New trial record